Genetic Susceptibility to Acute Viral Bronchiolitis

Anu Pasanen(Oulu University Hospital), Fedik Rahimov(AbbVie (United States)), Dawn Waterworth(GlaxoSmithKline (United States)), Robert Graham(GenProMarkers (United States)), Mikko Hallman(Oulu University Hospital), Antti Hakanen, Jani T. Tikkanen(University of Oulu), George Okafo, Kati Kristiansson, Minna K. Karjalainen(Oulu University of Applied Sciences), Simonne Longerich, Anders Mälarstig(Karolinska Institutet), Anna Vlahiotis, Matti Korppi(Oulu University Hospital), Coralie Viollet(AstraZeneca (United Kingdom)), Tomi P. Mäkelä(University of Helsinki), Marco Hautalahti, Mika Rämet(Tampere University of Applied Sciences), Markus Perola(Broad Institute), Jari A. Laukkanen(University of Eastern Finland), Outi Tuovila, Bridget Riley-Gills, Raisa Serpi, Matthias Gossel, Howard J. Jacob(Medical College of Wisconsin), Terhi Kilpi(Finnish Institute for Health and Welfare), Taneli Raivio(University of Helsinki), Nicole Renaud(Novartis (United States)), Margaret G. Ehm(GlaxoSmithKline (United States)), Aarno Palotie(Broad Institute), Joseph Maranville(Finnish Institute for Health and Welfare), Jeffrey F. Waring(AbbVie (United States)), Chris O’Donnell, Mark McCarthy(GlaxoSmithKline (United States)), Clément Chatelain, Slavé Petrovski(AstraZeneca (United Kingdom)), Bridget Riley-Gillis, Kirsi Auro, Robert M. Plenge, Minna Ruddock, Mark J. Daly(Broad Institute), Jukka Partanen, Rion Pendergrass, Chia-Yen Chen, Sally John, Petri Virolainen, Veli-Matti Kosma(University of Eastern Finland), Karol Estrada(Erasmus MC), K. Klinger(Sanofi (France)), Jaakko Kaprio(University of Helsinki)
The Journal of Infectious Diseases
September 17, 2024
Cited by 9


Related Papers